Publications for Michael Barnett
Publications for Michael Barnett
2016
Garg, N., Yuki, N., Park, S., Barnett, M.,
Kiernan, M. (2016). Acute bulbar, neck and limb
weakness with monospecific anti-GT1a
antibody: A rare localized subtype of
Guillain-Barre sydnrome. Muscle and Nerve,
53(1), 143-146. <a
href="http://dx.doi.org/10.1002/mus.24935">[M
ore Information]</a>
Barnett, M., Mathey, E., Kiernan, M., Pollard, J.
(2016). Axon damage in central nervous system
and peripheral nervous system inflammatory
demyelinating diseases: common and divergent
pathways of dysfunction and tissue damage.
Current Opinion In Neurology, 29(3), 213-221.
<a
href="http://dx.doi.org/10.1097/WCO.00000000
00000334">[More Information]</a>
Filingeri, D., Chaseling, G., Hoang, P., Barnett,
M., Davis, S., Jay, O. (2016). Effects of
exercise-induced increases in body temperatures
on local skin thermal sensitivity in Multiple
Sclerosis patients. Experimental Biology Meeting
2016, Bethesda, MD: Federation of American
Societies for Experimental Biology.
Barnett, M., McLeod, J., Hammond, S., Kurtzke,
J. (2016). Migration and multiple sclerosis in
immigrants from United Kingdom and Ireland to
Australia: a reassessment III: risk of multiple
sclerosis in UKI immigrants and Australian-born
in Hobart, Tasmania. Journal of Neurology,
263(4), 792-798. <a
href="http://dx.doi.org/10.1007/s00415-016-805
9-6">[More Information]</a>
Barnett, M., McLeod, J., Hammond, S., Kurtzke,
J. (2016). Migration and multiple sclerosis in
immigrants from United Kingdom and Ireland to
Australia: a reassessment. III: risk of multiple
sclerosis in UKI immigrants and Australian-born
in Hobart, Tasmania. Journal of Neurology,
263(4), 792-798. <a
href="http://dx.doi.org/10.1007/s00415-016-805
9-6">[More Information]</a>
Klistorner, A., Wang, C., Yiannikas, C., Graham,
S., Parratt, J., Barnett, M. (2016). Progressive
injury in chronic multiple sclerosis lesions is
gender-specific: A DTI study. Reviews in
Australian Studies, 11(2), 1-11. <a
href="http://dx.doi.org/10.1371/journal.pone.014
9245">[More Information]</a>
Ramanathan, S., Prelog, K., Barnes, E., Tantsis,
E., Reddel, S., Henderson, A., Vucic, S.,
Gorman, M., Benson, L., Alper, G., Barnett, M.,
Parratt, J., Hardy, T., Merheb, V., Nosadini, M.,
Fung, V., Brilot-Turville, F., Dale, R., et al
(2016). Radiological differentiation of optic
neuritis with myelin oligodendrocyte
glycoprotein antibodies, aquaporin-4 antibodies,
and multiple sclerosis. Multiple Sclerosis
Journal, 22(4), 470-482. <a
href="http://dx.doi.org/10.1177/1352458515593
406">[More Information]</a>
Spelman, T., Mekhael, L., Burke, T.,
Butzkueven, H., Hodgkinson, S., Havrdova, E.,
Horakova, D., Duquette, P., Izquierdo, G.,
Grand' Maison, F., Barnett, M., Vucic, S., et al
(2016). Risk of early relapse following the
switch from injectables to oral agents for
multiple sclerosis. European Journal of
Neurology, 23(4), 729-776. <a
href="http://dx.doi.org/10.1111/ene.12929">[Mo
re Information]</a>
Warrender-Sparkes, M., Spelman, T., Izquierdo,
G., Trojano, M., Lugaresi, A., Grand'Maison, F.,
Havrdova, E., Horakova, D., Boz, C., Barnett,
M., et al (2016). The effect of oral
immunomodulatory therapy on treatment uptake
and persistence in multiple sclerosis. Multiple
Sclerosis Journal, 22(4), 520-532. <a
href="http://dx.doi.org/10.1177/1352458515594
041">[More Information]</a>
2015
Broadley, S., Barnett, M., Boggild, M., Brew, B.,
Butzkueven, H., Heard, R., Hodgkinson, S.,
Kermode, A., Lechner-Scott, J., Macdonell, R.,
Parratt, J., Reddel, S., Spies, J., Pollard, J., et al
(2015). A new era in the treatment of multiple
sclerosis. Medical Journal of Australia, 203(3),
139-141. <a
href="http://dx.doi.org/10.5694/mja14.01218">[
More Information]</a>
Gu, B., Field, J., Dutertre, S., Ou, A., Kilpatrick,
T., Lechner-Scott, J., Scott, R., Lea, R., Taylor,
B., Stankovich, J., et al (2015). A rare P2X7
variant Arg307Gln with absent pore formation
function protects against neuroinflammation in
multiple sclerosis. Human Molecular Genetics,
24(19), 5644-5654. <a
href="http://dx.doi.org/10.1093/hmg/ddv278">[
More Information]</a>
Wang, C., Paling, D., Chen, L., Hatton, S.,
Lagopoulos, J., Aw, S., Kiernan, M., Barnett, M.
(2015). Axonal conduction in multiple sclerosis:
A combined magnetic resonance imaging and
electrophysiological study of the medial
longitudinal fasciculus. Multiple Sclerosis
Journal, 21(7), 905-915. <a
href="http://dx.doi.org/10.1177/1352458514556
301">[More Information]</a>
Hardy, T., Beadnall, H., Sutton, I., Mohamed,
A., Buckland, M., Barnett, M. (2015). Balo's
concentric sclerosis and tumefactive
demyelination: A shared immunopathogenesis?
Journal of the Neurological Sciences, 348(1-2),
Publications for Michael Barnett
279-281. <a
href="http://dx.doi.org/10.1016/j.jns.2014.11.024
">[More Information]</a>
Hardy, T., O’Brien, B., Gerbis, N., Barnett, M.,
Reddel, S., Brewer, J., Herkes, G., Silberstein,
P., Garsia, R., Watson, J., Gupta, R., Parratt, J.,
et al (2015). Brain histopathology in three cases
of Susac's syndrome: Implications for lesion
pathogenesis and treatment. Journal of
Neurology, Neurosurgery, and Psychiatry, 86(5),
582-584. <a
href="http://dx.doi.org/10.1136/jnnp-2014-30824
0">[More Information]</a>
Mathey, E., Park, S., Hughes, R., Pollard, J.,
Armati, P., Barnett, M., Taylor, B., Dyck, J.,
Kiernan, M., Lin, C. (2015). Chronic
inflammatory demyelinating
polyradiculoneuropathy: from pathology to
phenotype. Journal of Neurology, Neurosurgery
and Psychiatry, 86(9), 973-985. <a
href="http://dx.doi.org/10.1136/jnnp-2014-30969
7">[More Information]</a>
Kalincik, T., Jokubaitis, V., Izquierdo, G.,
Duquette, P., Girard, M., Grammond, P.,
Lugaresi, A., Oreja-Guevara, C., Bergamaschi,
R., Hupperts, R., Barnett, M., et al (2015).
Comparative effectiveness of glatiramer acetate
and interferon beta formulations in
relapsing-remitting multiple sclerosis. Multiple
Sclerosis Journal, 21(9), 1159-1171. <a
href="http://dx.doi.org/10.1177/1352458514559
865">[More Information]</a>
Spelman, T., Kalincik, T., Zhang, A., Pellegrini,
F., Wiendl, H., Kappos, L., Tsvetkova, L.,
Belachew, S., Hyde, R., Barnett, M., et al (2015).
Comparative efficacy of switching to
natalizumab in active multiple sclerosis. Annals
of Clinical and Translational Neurology, 2(4),
373-387. <a
href="http://dx.doi.org/10.1002/acn3.180">[Mor
e Information]</a>
Klistorner, A., Vootakuru, N., Wang, C.,
Yiannikas, C., Graham, S., Parratt, J., Garrick,
R., Levin, N., Masters, L., Lagopoulos, J.,
Barnett, M. (2015). Decoding diffusivity in
multiple sclerosis: analysis of optic radiation
lesional and non-lesional white matter. PloS One,
10(3), 1-23. <a
href="http://dx.doi.org/10.1371/journal.pone.012
2114">[More Information]</a>
Kalincik, T., Cutter, G., Spelman, V., Jokubaitis,
V., Havrdova, E., Horakova, D., Trojano, M.,
Izquierdo, G., Girard, M., Duquette, P., Barnett,
M., et al (2015). Defining reliable disability
outcomes in multiple sclerosis. Brain, 138(11),
3287-3298. <a
href="http://dx.doi.org/10.1093/brain/awv258">[
More Information]</a>
Buzzard, K., Reddel, S., Yiannikas, K.,
Riminton, S., Barnett, M., Hardy, T. (2015).
Distinguishing Susac's syndrome from multiple
sclerosis. Journal of Neurology, 262(7),
1613-1621. <a
href="http://dx.doi.org/10.1007/s00415-014-762
8-9">[More Information]</a>
Ribbons, K., McElduff, P., Boz, C., Trojano, M.,
Izquierdo, G., Duquette, P., Girard, M., Grand'
Maison, F., Hupperts, R., Grammond, P.,
Barnett, M., et al (2015). Male Sex Is
Independently Associated with Faster Disability
Accumulation in Relapse-Onset MS but Not in
Primary Progressive MS. PloS One, 10(6), 1-11.
<a
href="http://dx.doi.org/10.1371/journal.pone.012
2686">[More Information]</a>
Jokubaitis, V., Spelman, T., Kalincik, T.,
Izquierdo, G., Grand'Maison, F., Duquette, P.,
Girard, M., Lugaresi, A., Grammond, P.,
Hupperts, R., Barnett, M., et al (2015). Predictors
of disability worsening in clinically isolated
syndrome. Annals of Clinical and Translational
Neurology, 2(5), 479-491. <a
href="http://dx.doi.org/10.1002/acn3.187">[Mor
e Information]</a>
Kalincik, T., Horakova, D., Spelman, T.,
Jokubaitis, V., Trojano, M., Lugaresi, A.,
Izquierdo, G., Rozsa, C., Grammond, P.,
Alroughani, R., Barnett, M., et al (2015). Switch
to natalizumab versus fingolimod in active
relapsing-remitting multiple sclerosis. Annals of
Neurology, 77(3), 425-435. <a
href="http://dx.doi.org/10.1002/ana.24339">[Mo
re Information]</a>
Beadnall, H., Kuppanda, K., O'Connell, A.,
Hardy, T., Reddel, S., Barnett, M. (2015).
Tablet-based screening improves continence
management in multiple sclerosis. Annals of
Clinical and Translational Neurology, 2(6),
679-687. <a
href="http://dx.doi.org/10.1002/acn3.205">[Mor
e Information]</a>
Garg, N., Reddel, S., Miller, D., Chataway, J.,
Riminton, S., Barnett, Y., Masters, L., Barnett,
M., Hardy, T. (2015). The corpus callosum in the
diagnosis of multiple sclerosis and other CNS
demyelinating and inflammatory diseases.
Journal of Neurology, Neurosurgery, and
Psychiatry, 86(12), 1374-1382. <a
href="http://dx.doi.org/10.1136/jnnp-2014-30964
9">[More Information]</a>
2014
Ramanathan, S., Reddel, S., Henderson, A.,
Parratt, J., Barnett, M., Gatt, P., Merheb, V.,
Kumaran, R., Pathmanandavel, K., Sinmaz, N.,
Yiannikas, K., Vucic, S., Stewart, G., Booth, D.,
Dale, R., Brilot-Turville, F., et al (2014).
Publications for Michael Barnett
Antibodies to myelin oligodendrocyte
glycoprotein in bilateral and recurrent optic
neuritis. Neurology: Neuroimmunology and
Neuroinflammation, 1(4), 1-12. <a
href="http://dx.doi.org/10.1212/NXI.000000000
0000040">[More Information]</a>
Klistorner, A., Sriram, P., Vootakuru, N., Wang,
C., Barnett, M., Garrick, R., Parratt, J., Levin, N.,
Raz, N., van der Walt, A., Masters, L., et al
(2014). Axonal loss of retinal neurons in multiple
sclerosis associated with optic radiation lesions.
Neurology, 82(24), 2165-2172. <a
href="http://dx.doi.org/10.1212/WNL.00000000
00000522">[More Information]</a>
Barnett, Y., Sutton, I., Ghadiri, M., Masters, L.,
Zivadinov, R., Barnett, M. (2014). Conventional
and Advanced Imaging in Neuromyelitis Optica.
American Journal Of Neuroradiology, 35(8),
1458-1466.
Malik, O., Donnelly, A., Barnett, M. (2014). Fast
Facts: Multiple Sclerosis 3rd edition. Oxford:
Health Press Limited.
Jokubaitis, V., Li, V., Kalincik, T., Izquierdo, G.,
Hodgkinson, S., Alroughani, R., Lechner-Scott,
J., Lugaresi, A., Duquette, P., Girard, M.,
Barnett, M., et al (2014). Fingolimod after
natalizumab and the risk of short-term relapse.
Neurology, 82(14), 1204-1211. <a
href="http://dx.doi.org/10.1212/WNL.00000000
00000283">[More Information]</a>
Alshowaeir, D., Yiannikas, C., Garrick, R.,
Parratt, J., Barnett, M., Graham, S., Klistorner,
A. (2014). Latency of multifocal Visual Evoked
Potentials in non-optic neuritis eyes of multiple
sclerosis patients associated with optic radiation
lesions. Investigative Ophthalmology & Visual
Science, 55(6), 3758-3764. <a
href="http://dx.doi.org/10.1167/iovs.14-1457">[
More Information]</a>
Hughes, S., Spelman, T., Gray, O., Boz, C.,
Trojano, M., Lugaresi, A., Izquierdo, G.,
Duquette, P., Girard, M., Grand' Maison, F.,
Barnett, M., Vucic, S., et al (2014). Predictors
and dynamics of postpartum relapses in women
with multiple sclerosis. Multiple Sclerosis
Journal, 20(6), 739-746. <a
href="http://dx.doi.org/10.1177/1352458513507
816">[More Information]</a>
Ghadiri, M., Buckland, M., Sutton, I., Al
Jahdhami, S., Flanagan, S., Heard, R., Barnett,
Y., Brennan, J., Barnett, M. (2014). Progressive
Neuropsychiatric Symptoms and Motor
Impairment. JAMA Neurology, 71(6), 794-798.
<a
href="http://dx.doi.org/10.1001/jamaneurol.2013
.6308">[More Information]</a>
Sriram, P., Wang, C., Yiannikas, C., Garrick, R.,
Barnett, M., Parratt, J., Graham, S., Arvind
Srinivasan, H., Klistorner, A. (2014).
Relationship between optical coherence
tomography and electrophysiology of the visual
pathway in non-optic neuritis eyes of multiple
sclerosis patients. PloS One, 9(8), 1-10. <a
href="http://dx.doi.org/10.1371/journal.pone.010
2546">[More Information]</a>
Spelman, T., Gray, O., Trojano, M., Petersen, T.,
Izquierdo, G., Lugaresi, A., Hupperts, R.,
Bergamaschi, R., Duquette, P., Grammond, P.,
Barnett, M., Vucic, S., et al (2014). Seasonal
variation of relapse rate in multiple sclerosis is
latitude dependent. Annals of Neurology, 76(6),
880-890.
Parnell, G., Gatt, P., Krupa, M., Dorothee, N.,
McKay, F., Schibeci, S., Batten, M., Baranzini,
S., Henderson, A., Barnett, M., Vucic, S.,
Stewart, G., Booth, D., et al (2014). The
autoimmune disease-associated transcription
factors EOMES and TBX21 are dysregulated in
multiple sclerosis and define a molecular subtype
of disease. Clinical Immunology, 151(1), 16-24.
<a
href="http://dx.doi.org/10.1016/j.clim.2014.01.0
03">[More Information]</a>
Broadley, S., Barnett, M., Boggild, M., Brew, B.,
Butzkueven, H., Heard, R., Hodgkinson, S.,
Kermode, A., Lechner-Scott, J., Macdonell, R.,
Parratt, J., Reddel, S., Spies, J., Pollard, J., et al
(2014). Therapeutic approaches to disease
modifying therapy for multiple sclerosis in
adults: An Australian and New Zealand
perspective Part 1 Historical and established
therapies. Journal of Clinical Neuroscience,
21(11), 1835-1846. <a
href="http://dx.doi.org/10.1016/j.jocn.2014.01.0
16">[More Information]</a>
Broadley, S., Barnett, M., Boggild, M., Brew, B.,
Butzkueven, H., Heard, R., Hodgkinson, S.,
Kermode, A., Lechner-Scott, J., Macdonell, R.,
Parratt, J., Reddel, S., Spies, J., Pollard, J., et al
(2014). Therapeutic approaches to disease
modifying therapy for multiple sclerosis in
adults: An Australian and New Zealand
perspective Part 2 New and emerging therapies
and their efficacy. Journal of Clinical
Neuroscience, 21(11), 1847-1856.
Broadley, S., Barnett, M., Boggild, M., Brew, B.,
Butzkueven, H., Heard, R., Hodgkinson, S.,
Kermode, A., Lechner-Scott, J., Macdonell, R.,
Parratt, J., Reddel, S., Spies, J., Pollard, J., et al
(2014). Therapeutic approaches to disease
modifying therapy for multiple sclerosis in
adults: An Australian and New Zealand
perspective Part 3 Treatment practicalities and
recommendations. Journal of Clinical
Neuroscience, 21(11), 1857-1865. <a
href="http://dx.doi.org/10.1016/j.jocn.2014.01.0
Publications for Michael Barnett
17">[More Information]</a>
2013
Klistorner, A., Garrick, R., Barnett, M., Graham,
S., Arvind Srinivasan, H., Sriram, P., Yiannikas,
C. (2013). Axonal loss in non-optic neuritis eyes
of patients with multiple sclerosis linked to
delayed visual evoked potential. Neurology,
80(3), 242-245. <a
href="http://dx.doi.org/10.1212/WNL.0b013e31
827deb39">[More Information]</a>
Verheul, F., Smolders, J., Trojano, M., Lepore,
V., Zwanikken, C., Amato, M., Grand'Maison,
F., Butzkueven, H., Marrosu, M., Duquette, P.,
Barnett, M., et al (2013). Fluctuations of MS
births and UV-light exposure. Acta Neurologica
Scandinavica, 127(5), 301-308. <a
href="http://dx.doi.org/10.1111/ane.12007">[Mo
re Information]</a>
Lin, R., Charlesworth, J., Stankovich, J., Perreau,
V., Brown, M., Taylor, B., Baxter, A., Kermode,
A., Bahlo, M., Booth, D., Stewart, G., Barnett,
M., Heard, R., et al (2013). Identity-by-Descent
Mapping to Detect Rare Variants Conferring
Susceptibility to Multiple Sclerosis. PloS One,
8(3), 1-8. <a
href="http://dx.doi.org/10.1371/journal.pone.005
6379">[More Information]</a>
Kaushik, M., Wang, C., Barnett, M., Garrick, R.,
Parratt, J., Graham, S., Sriram, P., Yiannikas, C.,
Klistorner, A. (2013). Inner Nuclear Layer
Thickening Is Inversley Proportional to Retinal
Ganglion Cell Loss in Optic Neuritis. PloS One,
8(10), 1-8. <a
href="http://dx.doi.org/10.1371/journal.pone.007
8341">[More Information]</a>
Kalinick, T., Spelman, T., Trojano, M.,
Duquette, P., Izquierdo, G., Grammond, P.,
Lugaresi, A., Hupperts, R., Cristiano, E., Van
Pesch, V., Barnett, M., Vucic, S., et al (2013).
Persistence on Therapy and Propensity Matched
Outcome Comparison of Two Subcutaneous
Interferon Beta 1a Dosages for Multiple
Sclerosis. PloS One, 8(5), 1-9. <a
href="http://dx.doi.org/10.1371/journal.pone.006
3480">[More Information]</a>
Barnett, M., Hardy, T., Garsia, R., Halmagyi, G.,
Lewis, S., Harrisberg, B., Fulham, M. (2013).
Response to Letter to the Editor: Susac's
syndrome. Journal of the Neurological Sciences,
314(1-2), 183-183. <a
href="http://dx.doi.org/10.1016/j.jns.2011.11.030
">[More Information]</a>
Kalincik, T., Vivek, V., Jokubaitis, V.,
Lechner-Scott, J., Trojano, M., Izquierdo, G.,
Lugaresi, A., Grand'Maison, F., Hupperts, R.,
Oreja-Guevara, C., Vucic, S., Barnett, M., et al
(2013). Sex as a determinant of relapse incidence
and progressive course of multiple sclerosis.
Brain, 136(12), 3609-3617. <a
href="http://dx.doi.org/10.1093/brain/awt281">[
More Information]</a>
Jokubaitis, V., Spelman, T., Lechner-Scott, J.,
Barnett, M., Shaw, C., Vucic, S., Liew, D.,
Butzkueven, H., Slee, M. (2013). The Australian
Multiple Sclerosis (MS) immunotherapy study: a
prospective, multicentre study of drug utilisation
using the MSBase platform. PloS One, 8(3), 1-9.
<a
href="http://dx.doi.org/10.1371/journal.pone.005
9694">[More Information]</a>
Minagar, A., Barnett, M., Benedict, R., Pelletier,
D., Pirko, I., Sahraian, M., Frohman, E.,
Zivadinov, R. (2013). The thalamus and multiple
sclerosis: Modern views on pathologic, imaging,
and clinical aspects. Neurology, 80(2), 210-219.
<a
href="http://dx.doi.org/10.1212/WNL.0b013e31
827b910b">[More Information]</a>
2012
Meyniel, C., Spelman, T., Jokubaitis, V.,
Trojano, M., Izquierdo, G., Grand'Maison, F.,
Oreja-Guevara, C., Boz, C., Lugaresi, A., Girard,
M., Barnett, M., et al (2012). Country, Sex,
EDSS Change and Therapy Choice
Independently Predict Treatment Discontinuation
in Multiple Sclerosis and Clinically Isolated
Syndrome. PloS One, 7(6), 1-8. <a
href="http://dx.doi.org/10.1371/journal.pone.003
8661">[More Information]</a>
Simon, N., Parratt, J., Barnett, M., Buckland, M.,
Gupta, R., Hayes, M., Masters, L., Reddel, S.
(2012). Expanding the clinical, radiological and
neuropathological phenotype of chronic
lymphocytic inflammation with pontine
perivascular enhancement responsive to steroids
(CLIPPERS). Journal of Neurology,
Neurosurgery, and Psychiatry, 83(1), 15-22. <a
href="http://dx.doi.org/10.1136/jnnp-2011-30105
4">[More Information]</a>
Bien, C., Vincent, A., Barnett, M., Becker, A.,
Blumcke, I., Graus, F., Jellinger, K., Reuss, D.,
Ribalta, T., Schlegel, J., et al (2012).
Immunopathology of autoantibody-associated
encephalitides: clues for pathogenesis. Brain,
135(Pt 5), 1622-1638. <a
href="http://dx.doi.org/10.1093/brain/aws082">[
More Information]</a>
Chohan, G., Barnett, Y., Gibson, J., Reddel, S.,
Barnett, M. (2012). Langerhans cell histiocytosis
with refractory central nervous system
involvement responsive to infliximab. Journal of
Neurology, Neurosurgery, and Psychiatry, 83(5),
573-575. <a
href="http://dx.doi.org/10.1136/jnnp-2011-30057
5">[More Information]</a>
Publications for Michael Barnett
Barnett, M., Prineas, J., Buckland, M., Parratt, J.,
Pollard, J. (2012). Massive astrocyte destruction
in neuromyelitis optica despite natalizumab
therapy. Multiple Sclerosis Journal, 18(1),
108-112. <a
href="http://dx.doi.org/10.1177/1352458511421
185">[More Information]</a>
C., Barnett, M., et al (2012). The Kurtzke EDSS
rank stability increases 4 years after the onset of
multiple sclerosis: results from the MSBase
Registry. Journal of Neurology, Neurosurgery
and Psychiatry, 83(3), 305-310. <a
href="http://dx.doi.org/10.1136/jnnp-2011-30105
1">[More Information]</a>
Bukhari, W., Barnett, M., Prain, K., Broadley, S.
(2012). Molecular Pathogenesis of Neuromyelitis
Optica. International Journal of Molecular
Sciences, 13(10), 12970-12993. <a
href="http://dx.doi.org/10.3390/ijms131012970"
>[More Information]</a>
2011
Barnett, M., Sutton, I. (2012). Neuromyelitis
optica: not a multiple sclerosis variant. Current
Opinion In Neurology, 25(3), 215-220. <a
href="http://dx.doi.org/10.1097/WCO.0b013e32
83533a3f">[More Information]</a>
Barnett, M., Hardy, T., Garsia, R., Halmagyi, G.,
Lewis, S., Harrisberg, B., Fulham, M. (2012).
Response to Letter to the Editor: Susac's
syndrome. Journal of the Neurological Sciences,
314(1-2), 183-183. <a
href="http://dx.doi.org/10.1016/j.jns.2011.11.030
">[More Information]</a>
Hurelbrink, C., Barnett, Y., Buckland, M.,
Wilkinson, M., Leicester, J., Anderson, C.,
Brennan, J., Barnett, M. (2012). Revisiting
cerebral thromboangiitis obliterans. Journal of
the Neurological Sciences, 317(1-2), 141-145. <a
href="http://dx.doi.org/10.1016/j.jns.2012.03.011
">[More Information]</a>
Hardy, T., Barnett, M., Mohamed, A., Garsia, R.,
Davies, L. (2012). Severe Bickerstaffs
encephalitis treated with Rituximab: Serum and
CSF GQ1b antibodies. Journal of
Neuroimmunology, 251(1/2), 107-109. <a
href="http://dx.doi.org/10.1016/j.jneuroim.2012.
07.008">[More Information]</a>
Disanto, G., Morahan, J., Barnett, M.,
Giovannoni, G., Ramagopalan, S. (2012). The
evidence for a role of B cells in multiple
sclerosis. Neurology, 78(11), 823-832. <a
href="http://dx.doi.org/10.1212/WNL.0b013e31
8249f6f0">[More Information]</a>
Lechner-Scott, J., Spencer, B., de Malmanche,
T., Attia, J., Fitzgerald, M., Trojano, M.,
Francois, G., Gomez, J., Izquierdo, G., Duquette,
P., Barnett, M., et al (2012). The frequency of
CSF oligoclonal banding in multiple sclerosis
increases with latitude. Multiple Sclerosis
Journal, 18(7), 974-982. <a
href="http://dx.doi.org/10.1177/1352458511431
729">[More Information]</a>
Hughes, S., Spelman, T., Trojano, M., Lugaresi,
A., Izquierdo, G., Grand'Maison, F., Duquette,
P., Girard, M., Grammond, P., Oreja-Guevara,
Barnett, M., Chohan, G., Davies, L. (2011).
Blurred vision and pain in the eye. Medical
Journal of Australia, 195(6), 329-332. <a
href="http://dx.doi.org/10.5694/mja11.10707">[
More Information]</a>
Ly, L., Barnett, M., Zheng, Y., Gulati, T.,
Prineas, J., Crossett, B. (2011). Comprehensive
Tissue Processing Strategy for Quantitative
Proteomics of Formalin-fixed Multiple Sclerosis
Lesions. Journal of Proteome Research, 10(10),
4855-4868. <a
href="http://dx.doi.org/10.1021/pr200672n">[M
ore Information]</a>
Ahmed, R., Buckland, M., Davies, L., Halmagyi,
G., Rogers, S., Oberste, M., Barnett, M. (2011).
Enterovirus 71 meningoencephalitis
complicating rituximab therapy. Journal of the
Neurological Sciences, 305(1-2), 149-151. <a
href="http://dx.doi.org/10.1016/j.jns.2011.03.009
">[More Information]</a>
Barnett, M., Barnett, Y., Burke, D., Willison, H.
(2011). Spinal nerve root hypertrophy in chronic
ataxic neuropathy with antiglycolipid IgM
antibodies. Journal of Neurology, Neurosurgery
and Psychiatry, 82(1), 97. <a
href="http://dx.doi.org/10.1136/jnnp.2010.20509
6">[More Information]</a>
Hardy, T., Garsia, R., Halmagyi, G., Lewis, S.,
Harrisberg, B., Fulham, M., Barnett, M. (2011).
Tumour necrosis factor (TNF) inhibitor therapy
in Susac's syndrome. Journal of the Neurological
Sciences, 302(1-2), 126-128. <a
href="http://dx.doi.org/10.1016/j.jns.2010.11.016
">[More Information]</a>
2010
Henderson, A., Barnett, M., Parratt, J. (2010).
Reply. Annals of Neurology, 68(5), 768. <a
href="http://dx.doi.org/10.1002/ana.22033">[Mo
re Information]</a>
2009
Sutton, I., Lahoria, R., Tan, I., Clouston, P.,
Barnett, M. (2009). CNS demyelination and
quadrivalent HPV vaccination. Multiple
Sclerosis: clinical and laboratory research,
15(1), 116-119. <a
href="http://dx.doi.org/10.1177/1352458508096
868">[More Information]</a>
Barnett, M., Parratt, J., Cho, E., Prineas, J.
Publications for Michael Barnett
(2009). Immunoglobulins and complement in
postmortem multiple sclerosis tissue. Annals of
Neurology, 65(1), 32-46. <a
href="http://dx.doi.org/10.1002/ana.21524">[Mo
re Information]</a>
55(4), 458-468. <a
href="http://dx.doi.org/10.1002/ana.20016">[Mo
re Information]</a>
Barnett, M., Parratt, J., Pollard, J., Prineas, J.
(2009). MS: Is it One Disease? The International
M S Journal, 16(2), 57-65. <a
href="http://www.ncbi.nlm.nih.gov/entrez/query.
fcgi?cmd=Retrieve&db=pubmed&dopt=Abstract
&list_uids=19671369">[More Information]</a>
Barnett, M., Williams, D., Day, S., Macaskill, P.,
McLeod, J. (2003). Progressive increase in
incidence and prevalence of multiple sclerosis in
Newcastle, Australia: a 35-year study. Journal of
the Neurological Sciences, 213(1-2), 1-6.
Henderson, A., Barnett, M., Parratt, J., Prineas, J.
(2009). Multiple sclerosis: Distribution of
inflammatory cells in newly forming lesions.
Annals of Neurology, 66(6), 739-753. <a
href="http://dx.doi.org/10.1002/ana.21800">[Mo
re Information]</a>
Iland, H., Barnett, M., Pollard, J., Supple, S.
(2001). A spontaneous novel XK gene mutation
in a patient with McLeod syndrome. British
Journal of Haematology, 115, 369-372.
Granot, R., Lawrence, R., Barnett, M., Masters,
L., Rodriguez, M., Theocharous, C., Pamphlett,
R., Hersch, M. (2009). What lies beneath the
tent? JC-virus cerebellar granule cell
neuronopathy complicating sarcoidosis. Journal
of Clinical Neuroscience, 16(8), 1091-2. <a
href="http://dx.doi.org/10.1016/j.jocn.2008.07.0
91">[More Information]</a>
2007
McLeod, J., Barnett, M., Macaskill, P., Williams,
D. (2007). Long-term prognosis of multiple
sclerosis in Australia. Journal of the
Neurological Sciences, 256, 35-38. <a
href="http://dx.doi.org/10.1016/j.jns.2007.02.004
">[More Information]</a>
2006
Barnett, M., Henderson, A., Prineas, J. (2006).
The macrophage in MS: just a scavenger after
all? Pathology and pathogenesis of the acute MS
lesion. Multiple Sclerosis: clinical and
laboratory research, 12(2), 121-132. <a
href="http://www.ncbi.nlm.nih.gov/entrez/query.
fcgi?cmd=Retrieve&db=pubmed&dopt=Abstract
&list_uids=16629415">[More Information]</a>
Patani, (., Barnett, M., Prineas, J. (2006). The
pathology of impaired remyelination in multiple
sclerosis. 189th Meeting of the Pathological
Society of Great Britain and Ireland, United
Kingdom: John Wiley & Sons.
Barnett, M., Sutton, I. (2006). The pathology of
multiple sclerosis: a paradigm shift. Current
Opinion In Neurology, 19(3), 242-247. <a
href="http://www.ncbi.nlm.nih.gov/entrez/query.
fcgi?cmd=Retrieve&db=pubmed&dopt=Abstract
&list_uids=16702829">[More Information]</a>
2004
Barnett, M., Prineas, J. (2004). Relapsing And
Remitting Multiple Sclerosis: Pathology Of The
Newly Forming Lesion. Annals of Neurology,
2003
2001